ELL3
Basic information
Region (hg38): 15:43772605-43777315
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (52 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ELL3 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000025165.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 51 | 52 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 51 | 1 | 0 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ELL3 | protein_coding | protein_coding | ENST00000319359 | 11 | 4944 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.70e-12 | 0.200 | 125653 | 0 | 94 | 125747 | 0.000374 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.470 | 196 | 215 | 0.910 | 0.0000110 | 2552 |
Missense in Polyphen | 62 | 76.261 | 0.813 | 902 | ||
Synonymous | 0.546 | 71 | 77.1 | 0.921 | 0.00000341 | 768 |
Loss of Function | 0.908 | 21 | 26.0 | 0.808 | 0.00000119 | 294 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000750 | 0.000750 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000381 | 0.000381 |
Finnish | 0.000231 | 0.000231 |
European (Non-Finnish) | 0.000415 | 0.000413 |
Middle Eastern | 0.000381 | 0.000381 |
South Asian | 0.000492 | 0.000490 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Enhancer-binding elongation factor that specifically binds enhancers in embryonic stem cells (ES cells), marks them, and is required for their future activation during stem cell specification. Does not only bind to enhancer regions of active genes, but also marks the enhancers that are in a poised or inactive state in ES cells and is required for establishing proper RNA polymerase II occupancy at developmentally regulated genes in a cohesin-dependent manner. Probably required for priming developmentally regulated genes for later recruitment of the super elongation complex (SEC), for transcriptional activation during differentiation. Required for recruitment of P-TEFb within SEC during differentiation. Probably preloaded on germ cell chromatin, suggesting that it may prime gene activation by marking enhancers as early as in the germ cells. Promoting epithelial-mesenchymal transition (EMT) (By similarity). Elongation factor component of the super elongation complex (SEC), a complex required to increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA. Component of the little elongation complex (LEC), a complex required to regulate small nuclear RNA (snRNA) gene transcription by RNA polymerase II and III (PubMed:22195968). {ECO:0000250, ECO:0000269|PubMed:10882741, ECO:0000269|PubMed:22195968}.;
- Pathway
- Gene expression (Transcription);RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription
(Consensus)
Recessive Scores
- pRec
- 0.0831
Intolerance Scores
- loftool
- 0.925
- rvis_EVS
- 0.49
- rvis_percentile_EVS
- 79.38
Haploinsufficiency Scores
- pHI
- 0.0925
- hipred
- N
- hipred_score
- 0.394
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.963
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ell3
- Phenotype
Gene ontology
- Biological process
- DNA-templated transcription, elongation;transcription by RNA polymerase II;transcription elongation from RNA polymerase II promoter;spermatogenesis;regulation of epithelial to mesenchymal transition;positive regulation of DNA-templated transcription, elongation;snRNA transcription by RNA polymerase II;positive regulation of transcription by RNA polymerase II;stem cell differentiation;positive regulation of neurogenesis;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;positive regulation of neural precursor cell proliferation
- Cellular component
- nucleus;nucleoplasm;nucleolus;transcription elongation factor complex
- Molecular function
- protein binding;enhancer binding